Ecopipam Treatment of Tourette Syndrome

Clinical trial NCT01244633 · COMPLETED

Trial details

NCT number: NCT01244633
Sponsor: Psyadon Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tourette's Syndrome

Start date: 2010-10-01
Primary completion: 2012-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.